Stay updated with breaking news from Revised March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14.10.2023 - Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) was approved by the U.S. Food and Drug Administration (FDA) for the adjuvant treatment of adult and pediatric patients 12 years and older with completely resected stage IIB or ...
In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant improvement in recurrence-free survival compared to placebo1 CheckMate -76K marks the fifth Opdivo-based...
In this CME, learn more about implementing formal or informal collaboration with the primary care clinicians with whom you share care of your child patients.
Commodities can be a good hedge when inflation spikes. That said, trying to time episodes of inflation is a fool’s errand.
Pennsylvania House Judiciary Committee Announces Next Steps into Investigation into Commissioner Halcovage Investigation